CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Total	Common Stock	Additional Paid in Capital	Accumulated Deficit
Beginning Balances at Dec. 31, 2022	$ 48,339,114	$ 111,091	$ 49,029,712	$ (801,689)
Beginning Balance, shares at Dec. 31, 2022		11,109,077
Restricted stock grants issued		$ 380	(380)
Restricted stock grants issued, Shares		37,976
Restricted stock grant forfeiture		$ (32)	32
Restricted stock grant forfeitures, shares		(3,145)
Stock-based compensation	37,787		37,787
Net income	992,541			992,541
Dividends	(805,228)			(805,228)
Ending Balance at Mar. 31, 2023	48,564,214	$ 111,439	49,067,151	(614,376)
Ending Balance, shares at Mar. 31, 2023		11,143,908
Beginning Balances at Dec. 31, 2023	$ 48,246,027	$ 111,535	49,229,020	(1,094,528)
Beginning Balance, shares at Dec. 31, 2023	11,153,513	11,153,513
Restricted stock grants issued		$ 1,144	(1,144)
Restricted stock grants issued, Shares		114,378
Restricted stock grant forfeiture		$ (8)	8
Restricted stock grant forfeitures, shares		(843)
Stock-based compensation	$ 71,004		71,004
Net income	266,150			266,150
Dividends	(808,568)			(808,568)
Ending Balance at Mar. 31, 2024	$ 47,774,613	$ 112,671	$ 49,298,888	$ (1,636,946)
Ending Balance, shares at Mar. 31, 2024	11,267,048	11,267,048